Aerovate Therapeutics マネジメント
マネジメント 基準チェック /24
現在、CEO に関する十分な情報がありません。
主要情報
Tim Noyes
最高経営責任者
US$3.1m
報酬総額
| CEO給与比率 | 19.1% |
| CEO在任期間 | 3.5yrs |
| CEOの所有権 | n/a |
| 経営陣の平均在職期間 | 3yrs |
| 取締役会の平均在任期間 | 3.5yrs |
経営陣の近況
Recent updates
Here's Why Aerovate Therapeutics (NASDAQ:AVTE) Must Use Its Cash Wisely
Oct 01
Aerovate: Imatinib Delivery Change Leads To Targeting Of Massive PAH Market
Jun 11Here's Why We're Watching Aerovate Therapeutics' (NASDAQ:AVTE) Cash Burn Situation
May 24Aerovate Therapeutics (NASDAQ:AVTE) Is In A Good Position To Deliver On Growth Plans
Feb 09We're Not Very Worried About Aerovate Therapeutics' (NASDAQ:AVTE) Cash Burn Rate
Oct 17Aerovate Therapeutics (NASDAQ:AVTE) Is In A Good Position To Deliver On Growth Plans
Jul 04Aerovate Therapeutics (NASDAQ:AVTE) Is In A Good Position To Deliver On Growth Plans
Feb 28A Look At The Fair Value Of Aerovate Therapeutics, Inc. (NASDAQ:AVTE)
Jan 06Companies Like Aerovate Therapeutics (NASDAQ:AVTE) Are In A Position To Invest In Growth
Oct 14Here's Why We're Not Too Worried About Aerovate Therapeutics' (NASDAQ:AVTE) Cash Burn Situation
Jul 01We Think Aerovate Therapeutics (NASDAQ:AVTE) Can Afford To Drive Business Growth
Jan 22Companies Like Aerovate Therapeutics (NASDAQ:AVTE) Are In A Position To Invest In Growth
Sep 30CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$85m |
| Jun 30 2024 | n/a | n/a | -US$88m |
| Mar 31 2024 | n/a | n/a | -US$82m |
| Dec 31 2023 | US$3m | US$586k | -US$76m |
| Sep 30 2023 | n/a | n/a | -US$70m |
| Jun 30 2023 | n/a | n/a | -US$64m |
| Mar 31 2023 | n/a | n/a | -US$57m |
| Dec 31 2022 | US$704k | US$563k | -US$52m |
| Sep 30 2022 | n/a | n/a | -US$45m |
| Jun 30 2022 | n/a | n/a | -US$37m |
| Mar 31 2022 | n/a | n/a | -US$31m |
| Dec 31 2021 | US$5m | US$437k | -US$23m |
報酬と市場: Timの 総報酬 ($USD 3.07M ) は、 US市場 ($USD 649.07K ) の同規模の企業の平均を上回っています。
報酬と収益: Timの報酬は増加しましたが、会社は利益を上げていません。
CEO（最高経営責任者
Tim Noyes (62 yo)
3.5yrs
在職期間
US$3,070,657
報酬
Mr. Timothy P. Noyes, MBA, also known as Tim, has been the Chief Executive Officer of Aerovate Therapeutics, Inc. since May 2021 and has been its Director since April 2021. Mr. Noyes serves as Venture Part...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO & Director | 3.5yrs | US$3.07m | データなし | |
| CFO & Treasurer | 3.7yrs | US$2.13m | 0.017% $ 13.4k | |
| Founder | 6.3yrs | US$2.88m | 0.049% $ 37.9k | |
| Chief Scientific Officer | 2.3yrs | US$433.20k | 0.0056% $ 4.3k | |
| Chief Medical Officer | 4.5yrs | US$1.63m | 0.019% $ 14.9k | |
| Head of Regulatory Affairs | 4.2yrs | データなし | データなし | |
| Executive Vice President of Development Operations | 2.6yrs | データなし | データなし | |
| Senior Vice President of Quality | 2.3yrs | データなし | データなし | |
| Executive Vice President of Clinical Development | 1.8yrs | データなし | データなし | |
| Senior Vice President of Clinical Development | 1.8yrs | データなし | データなし |
3.0yrs
平均在職期間
61yo
平均年齢
経験豊富な経営陣: AVTEの経営陣は 経験豊富 であると考えられます ( 3年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO & Director | 3.6yrs | US$3.07m | データなし | |
| Independent Director | 1.3yrs | データなし | データなし | |
| Independent Director | 1.8yrs | US$568.54k | 0% $ 0 | |
| Independent Director | 4.3yrs | US$225.99k | 0% $ 0 | |
| Independent Director | 4.3yrs | US$174.80k | 0% $ 0 | |
| Independent Director | 3.8yrs | US$218.30k | 0% $ 0 | |
| Independent Director | 3.3yrs | US$185.80k | 0% $ 0 | |
| Independent Chairman of the Board | 1.3yrs | US$363.25k | 0% $ 0 |
3.5yrs
平均在職期間
57yo
平均年齢
経験豊富なボード: AVTEの 取締役会 は 経験豊富 であると考えられます ( 3.5年の平均在任期間)。